Akari Shigemi
- Pharmacology top 2%
- Infectious Diseases top 5%
- Epidemiology
- Clinical Biochemistry top 5%
- Molecular Medicine top 5%
- Co-authors
- Kazuaki MatsumotoYasuo TakedaKazuro IkawaNorifumi MorikawaErika WatanabeYuta YokoyamaYoshihiro ShimodozonoKatsushi Yamada
- Topics
- Antibiotics Pharmacokinetics and Efficacy (17 papers)Antimicrobial Resistance in Staphylococcus (12 papers)Pneumonia and Respiratory Infections (6 papers)
In The Last Decade
Akari Shigemi
31 papers receiving 642 citations
Peers
Comparison fields: 5 of 78
- Pharmacology 392
- Infectious Diseases 392
- Epidemiology 210
- Clinical Biochemistry 152
- Molecular Medicine 103
Countries citing papers authored by Akari Shigemi
This map shows the geographic impact of Akari Shigemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akari Shigemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akari Shigemi more than expected).
Fields of papers citing papers by Akari Shigemi
This network shows the impact of papers produced by Akari Shigemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akari Shigemi. The network helps show where Akari Shigemi may publish in the future.
Co-authorship network of co-authors of Akari Shigemi
This figure shows the co-authorship network connecting the top 25 collaborators of Akari Shigemi. A scholar is included among the top collaborators of Akari Shigemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akari Shigemi. Akari Shigemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 11 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 18 | |
| 9 | 15 | |
| 10 | 47 | |
| 11 | 19 | |
| 12 | 117 | |
| 13 | 49 | |
| 14 | 1 | |
| 15 | 28 | |
| 16 | 12 | |
| 17 | 97 | |
| 18 | 29 | |
| 19 | 10 | |
| 20 | 1 |
About Akari Shigemi
Akari Shigemi is a scholar working on Molecular Medicine, Pharmacology and Applied Microbiology and Biotechnology, having authored 31 papers that have together received 652 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (17 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (53 citations), Pharmacology (392 citations) and Clinical Biochemistry (152 citations). Akari Shigemi has collaborated with scholars based in Japan and Australia. Frequent co-authors include Kazuaki Matsumoto, Yasuo Takeda, Kazuro Ikawa, Norifumi Morikawa, Erika Watanabe, Yuta Yokoyama, Yoshihiro Shimodozono, Katsushi Yamada, Yoshio Takesue and Tomoyuki Yamada. Their work appears in journals such as International Journal of Antimicrobial Agents, Biological and Pharmaceutical Bulletin and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.